SPTBN1 and metabolic dysfunction-associated steatohepatitis: Nonsignificant fibrosis (F0–1) and advanced liver fibrosis (F3–4) diagnosis models evaluated in the NASH cohort were: FIB-4 alone, ELF alone, FIB-4 and ELF in multivariate analysis and FIB-4 and ELF sequential algorithm.